The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | J | Antiinfectives for systemic use | |
2 | J05 | Antivirals for systemic use | |
3 | J05A | Direct acting antivirals | |
4 | J05AG | Non-nucleoside reverse transcriptase inhibitors |
Code | Title | |
---|---|---|
J05AG01 | Nevirapine | |
J05AG02 | Delavirdine | |
J05AG03 | Efavirenz | |
J05AG04 | Etravirine | |
J05AG05 | Rilpivirine | |
J05AG06 |
Active Ingredient | Description | |
---|---|---|
Doravirine |
Doravirine is a pyridinone non-nucleoside reverse transcriptase inhibitor of HIV-1 and inhibits HIV-1 replication by non-competitive inhibition of HIV-1 reverse transcriptase (RT). Doravirine does not inhibit the human cellular DNA polymerases α, β, and mitochondrial DNA polymerase γ. |
|
Efavirenz |
Efavirenz is a NNRTI of HIV-1. Efavirenz is a non-competitive inhibitor of HIV-1 reverse transcriptase (RT) and does not significantly inhibit HIV-2 RT or cellular DNA polymerases (α, β, γ or δ). |
|
Etravirine |
Etravirine is an non-nucleoside reverse transcriptase inhibitors (NNRTI) of human immunodeficiency virus type 1 (HIV-1). Etravirine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme’s catalytic site. |
|
Nevirapine |
Nevirapine is a NNRTI of HIV-1. Nevirapine is a non-competitive inhibitor of the HIV-1 reverse transcriptase, but it does not have a biologically significant inhibitory effect on the HIV-2 reverse transcriptase or on eukaryotic DNA polymerases α, β, γ, or δ. |
|
Rilpivirine |
Rilpivirine is a diarylpyrimidine NNRTI of HIV-1. Rilpivirine activity is mediated by non-competitive inhibition of HIV-1 reverse transcriptase (RT). Rilpivirine does not inhibit the human cellular DNA polymerases α, β and γ. |
Title | Information Source | Document Type | |
---|---|---|---|
EDURANT Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
EFRIN Film-coated tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
INTELENCE Tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
NEVIRAPINE TEVA Tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
PIFELTRO Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
REKAMBYS Prolonged-release suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
STOCRIN Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |